LACAX
Price
$8.17
Change
-$0.35 (-4.11%)
Updated
Feb 21 closing price
Net Assets
2.56B
PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
29.57B
Ad is loading...

LACAX vs PMBPX

Header iconLACAX vs PMBPX Comparison
Open Charts LACAX vs PMBPXBanner chart's image
Columbia Acorn A
Price$8.17
Change-$0.35 (-4.11%)
VolumeN/A
Net Assets2.56B
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets29.57B
LACAX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LACAX vs. PMBPX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LACAX is a Hold and PMBPX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 29.6B vs. LACAX (2.56B). LACAX (0.00) and PMBPX (0.00) have matching dividends . LACAX was incepted earlier than PMBPX: LACAX (24 years) vs PMBPX (24 years). LACAX is a more actively managed with annual turnover of: 64.00 vs. PMBPX (10.10). PMBPX has a lower initial minimum investment than LACAX: PMBPX (0) vs LACAX (2000). PMBPX annual gain was more profitable for investors over the last year : 12.43 vs. LACAX (4.74). PMBPX return over 5 years is better than : 35.10 vs. LACAX (-31.98).
LACAXPMBPXLACAX / PMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years24 years-
Gain YTD-4.4441.864-238%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.56B29.6B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.7412.4338%
Returns for 3 years1.1127.854%
Returns for 5 years-31.9835.10-91%
Returns for 10 years-73.6592.30-80%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIEMX11.03-0.04
-0.36%
Alger Emerging Markets I
NYVBX19.55-0.30
-1.51%
Davis NY Venture B
RSPYX31.08-0.56
-1.77%
Victory RS Partners Y
VYSAX15.02-0.41
-2.66%
Voya Small Company I
LMOPX35.10-1.04
-2.88%
Patient Opportunity C